Meetings - The ASCO Post

This is Part 3 of Targeting Endocrine Resistance in HR-Positive/HER2-Negative Metastatic Breast Cancer, a three-part video roundtable series. Scroll down to watch the other videos from this Roundtable...

breast cancer

/ Targeting Endocrine Resistance in HR-Positive/HER2-Negative Metastatic Breast Cancer

HR-Positive/HER2-Negative Metastatic Breast Cancer With PIK3CA Mutation

This is Part 2 of Targeting Endocrine Resistance in HR-Positive/HER2-Negative Metastatic Breast Cancer, a three-part video roundtable series. Scroll down to watch the other videos from this Roundtable...

breast cancer

/ Targeting Endocrine Resistance in HR-Positive/HER2-Negative Metastatic Breast Cancer

Second-Line Treatment of HR-Positive/HER2-Negative ESR1-Mutated Metastatic Breast Cancer

This is Part 1 of Targeting Endocrine Resistance in HR-Positive/HER2-Negative Metastatic Breast Cancer, a three-part video roundtable series. Scroll down to watch the other videos from this Roundtable...

Targeting Endocrine Resistance in HR-Positive/HER2-Negative Metastatic Breast Cancer

Endocrine-Resistant HR-Positive/HER2-Negative Metastatic Breast Cancer

HR-Positive/HER2-Negative Metastatic Breast Cancer With PIK3CA Mutation

Second-Line Treatment of HR-Positive/HER2-Negative ESR1-Mutated Metastatic Breast Cancer

Addition of Hyperthermic Intraperitoneal Chemotherapy to Surgery for Recurrent Ovarian Cancer

Penpulimab Combination Therapy for First-Line Treatment of Hepatocellular Carcinoma

Global Adaptive Platform Trial for Glioblastoma to Evaluate Novel ATM Kinase Inhibitor

Healthy Women May Have Aneuploid Epithelial Cells Resembling Breast Cancer

Perioperative Toripalimab in Locoregionally Advanced Nasopharyngeal Carcinoma